x

Coronavirus

AstraZeneca Asks FDA to Authorize COVID Antibody Treatment

LONDON — Officials with drugmaker AstraZeneca have asked the U.S. Food and Drug Administration to authorize the emergency use of an antibody treatment to prevent COVID-19.

The company says the treatment, known as AZD7442, will be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention. AstraZeneca says the drug may help protect people whose immune systems don’t fully respond to vaccination.

U.S. demand for antibody treatments soared over the summer, particularly in Florida, Louisiana and Texas, where hospitalizations among unvaccinated patients threatened to overwhelm the health care system.

The drugs are lab versions of virus-blocking antibodies that help fight off infections. The treatments help the patient by supplying concentrated doses. The main antibody treatment used in the U.S. is Regeneron’s dual-antibody cocktail.

RELATED

ATHENS – While the New Democracy government is easing health restrictions for rabid anti-vaxxers, those fully vaccinated against COVID-19 may need a fourth shot in the autumn.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Sounds of Cyprus Performed Live in Times Square (Video)

NEW YORK – Talented artists Elena Chris, Peter Douskalis, and Alex Tasopoulos performed a concert of Cypriot music for New Yorkers and tourists in the center of the Big Apple, Times Square.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.